Edoxaban chloro pyridine acid impurity

Edoxaban chloro pyridine acid impurity is a structurally related synthetic byproduct arising from the chlorination of a pyridine ring in the edoxaban core scaffold. It features a 3-chloro-4-pyridine carboxylic acid moiety, retaining the tetrahydrofuran ether linkage characteristic of the parent anticoagulant. The substitution of a hydrogen atom with chlorine on the pyridine ring introduces steric and electronic perturbations, altering its pharmacophoric profile. This impurity serves as a critical HPLC reference standard for quantifying process-related variability in edoxaban API synthesis.